Sh Fosun Pharma reported CNY9.09B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Jiangsu Hengrui CNY 6.01B 449.22M Sep/2026
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Sh Pharmaceutical CNY 73.27B 4.06B Sep/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Wuxi Apptec CNY 9.07B 580.89M Sep/2026
Zz Pientze Pharmaceu CNY 1.54B 90.74M Sep/2026